Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have already had, or have been assessed as suitable for, a cryobiopsy procedure based on national or international medical guidelines, or after a previous diagnostic test did not give a clear result and a medical team discussed the case together.
- People whose procedure is being carried out in the bronchial endoscopy department at the New Civil Hospital of the University Hospitals of Strasbourg.
- People with a diffuse interstitial lung disease (a type of condition affecting lung tissue) where a specialist team meeting has decided a cryobiopsy is needed because scans and blood tests alone could not identify the specific type, or because surgery is not safe given the person's breathing condition, or as an alternative to surgical biopsy.
- People with lymph node abnormalities or growths in the chest area where, after a specialist team discussion, earlier procedures did not give a diagnosis — or, in cases where lymphoma is strongly suspected, where this procedure may be considered alongside another technique at the same time.
- People included in the study's retrospective (looking back at past cases) part: those who had a cryobiopsy, or a CT-guided lung biopsy to investigate a lung tissue condition or suspected lung tumour, since July 2024.
Who may not be able to join:
- People under 18 years of age.
- Women who are pregnant or breastfeeding.
- People who are under legal guardianship or a similar form of legal protection.
- People with an increased risk of bleeding — for example, those taking blood-thinning medications that have not been paused for the required amount of time, those with certain abnormal blood clotting results, those on two types of antiplatelet (anti-clotting) medications at the same time, or those with a low platelet count (confirm with trial site for specific values).
- People whose blood oxygen levels fall below 90% even when receiving oxygen at a low flow rate.
- People with serious pre-existing heart conditions, such as unstable chest pain, a recent heart attack, or heart failure that is not well controlled.
- People with known high blood pressure in the lungs (pulmonary hypertension) where measurements on a heart scan are above a certain level (confirm with trial site).
- People who are not able to give informed agreement to take part — for example, in an emergency situation or where there is difficulty understanding the information provided.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michele PORZIO, Doctor, Pulmonology Department - Nouvel Hôpital Civil - HUS
Phone: 03 88 24 04 03
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess the diagnostic performance of transbronchial cryobiopsy and EBUS cryobiopsy in both indications
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.